The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.

While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...

U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from Novavax.

An FDA committee will soon make recommendations about this fall’s Covid-19 vaccines while Novavax still awaits full FDA ...

The U.S. Food and Drug Administration has granted limited approval to Novavax Inc.'s COVID-19 vaccine, restricting its use to ...

The FDA granted Pfizer-BioNTech full approval for those 12 and older in ... the FDA and CDC are giving greater scrutiny to the shots. The FDA delayed the decision on the vaccine as it sought ...

Novavax's COVID-19 vaccine, Nuvaxovid™, receives limited FDA approval and triggers $175M milestone payment. Commercial ...

US health regulators have given final approval to Novavax's COVID vaccine after an unusual delay and have placed new ...

mRNA vaccines made by Pfizer and Moderna, have earned full FDA approval for certain age groups. Because the coronavirus continually mutates, manufacturers follow instructions from FDA to make one ...